133 related articles for article (PubMed ID: 21737646)
1. Combined valproic acid and celecoxib treatment induced synergistic cytotoxicity and apoptosis in neuroblastoma cells.
Chen Y; Tsai YH; Tseng SH
Anticancer Res; 2011 Jun; 31(6):2231-9. PubMed ID: 21737646
[TBL] [Abstract][Full Text] [Related]
2. Combination of atorvastatin and celecoxib synergistically induces cell cycle arrest and apoptosis in colon cancer cells.
Xiao H; Zhang Q; Lin Y; Reddy BS; Yang CS
Int J Cancer; 2008 May; 122(9):2115-24. PubMed ID: 18172863
[TBL] [Abstract][Full Text] [Related]
3. Sequential treatment of HPV E6 and E7-expressing TC-1 cells with bortezomib and celecoxib promotes apoptosis through p-p38 MAPK-mediated downregulation of cyclin D1 and CDK2.
Kim JE; Lee JI; Jin DH; Lee WJ; Park GB; Kim S; Kim YS; Wu TC; Hur DY; Kim D
Oncol Rep; 2014 May; 31(5):2429-37. PubMed ID: 24627094
[TBL] [Abstract][Full Text] [Related]
4. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib.
Zhang GS; Liu DS; Dai CW; Li RJ
Am J Hematol; 2006 Apr; 81(4):242-55. PubMed ID: 16550520
[TBL] [Abstract][Full Text] [Related]
5. Impact of histone deacetylase inhibitor valproic acid on the anticancer effect of etoposide on neuroblastoma cells.
Groh T; Hrabeta J; Poljakova J; Eckschlager T; Stiborova M
Neuro Endocrinol Lett; 2012; 33 Suppl 3():16-24. PubMed ID: 23353839
[TBL] [Abstract][Full Text] [Related]
6. COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib.
Grösch S; Tegeder I; Niederberger E; Bräutigam L; Geisslinger G
FASEB J; 2001 Dec; 15(14):2742-4. PubMed ID: 11606477
[TBL] [Abstract][Full Text] [Related]
7. Valproic acid induces p21 and topoisomerase-II (alpha/beta) expression and synergistically enhances etoposide cytotoxicity in human glioblastoma cell lines.
Das CM; Aguilera D; Vasquez H; Prasad P; Zhang M; Wolff JE; Gopalakrishnan V
J Neurooncol; 2007 Nov; 85(2):159-70. PubMed ID: 17534580
[TBL] [Abstract][Full Text] [Related]
8. Potentiation of anticancer effect of valproic acid, an antiepileptic agent with histone deacetylase inhibitory activity, by the cyclin-dependent kinase inhibitor P276-00 in human non-small-cell lung cancer cell lines.
Shirsath N; Rathos M; Chaudhari U; Sivaramakrishnan H; Joshi K
Lung Cancer; 2013 Nov; 82(2):214-21. PubMed ID: 24051085
[TBL] [Abstract][Full Text] [Related]
9. Celecoxib prevents neuroblastoma tumor development and potentiates the effect of chemotherapeutic drugs in vitro and in vivo.
Ponthan F; Wickström M; Gleissman H; Fuskevåg OM; Segerström L; Sveinbjörnsson B; Redfern CP; Eksborg S; Kogner P; Johnsen JI
Clin Cancer Res; 2007 Feb; 13(3):1036-44. PubMed ID: 17289900
[TBL] [Abstract][Full Text] [Related]
10. Enhanced sensitivity of celecoxib in human glioblastoma cells: Induction of DNA damage leading to p53-dependent G1 cell cycle arrest and autophagy.
Kang KB; Zhu C; Yong SK; Gao Q; Wong MC
Mol Cancer; 2009 Aug; 8():66. PubMed ID: 19706164
[TBL] [Abstract][Full Text] [Related]
11. Thrombospondin-1 peptide ABT-510 combined with valproic acid is an effective antiangiogenesis strategy in neuroblastoma.
Yang Q; Tian Y; Liu S; Zeine R; Chlenski A; Salwen HR; Henkin J; Cohn SL
Cancer Res; 2007 Feb; 67(4):1716-24. PubMed ID: 17308113
[TBL] [Abstract][Full Text] [Related]
12. Radiosensitivity enhancement by combined treatment of celecoxib and gefitinib on human lung cancer cells.
Park JS; Jun HJ; Cho MJ; Cho KH; Lee JS; Zo JI; Pyo H
Clin Cancer Res; 2006 Aug; 12(16):4989-99. PubMed ID: 16914589
[TBL] [Abstract][Full Text] [Related]
13. Combination of metformin and valproic acid synergistically induces cell cycle arrest and apoptosis in clear cell renal cell carcinoma.
Zhang X; Zhang X; Huang T; Geng J; Liu M; Zheng J
Int J Clin Exp Pathol; 2015; 8(3):2823-8. PubMed ID: 26045790
[TBL] [Abstract][Full Text] [Related]
14. [Cytotoxic activities of Celecoxib on leukemic cells and the synergistic effects of Celecoxib with Imatinib thereupon].
Li RJ; Gong FJ; Zhang GS
Zhonghua Yi Xue Za Zhi; 2006 May; 86(20):1417-20. PubMed ID: 16796927
[TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase-2 (COX-2)-dependent and -independent anticarcinogenic effects of celecoxib in human colon carcinoma cells.
Maier TJ; Schilling K; Schmidt R; Geisslinger G; Grösch S
Biochem Pharmacol; 2004 Apr; 67(8):1469-78. PubMed ID: 15041464
[TBL] [Abstract][Full Text] [Related]
16. p21Waf1/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid, tributyrin and sodium butyrate) in neuroblastoma cells.
Rocchi P; Tonelli R; Camerin C; Purgato S; Fronza R; Bianucci F; Guerra F; Pession A; Ferreri AM
Oncol Rep; 2005 Jun; 13(6):1139-44. PubMed ID: 15870934
[TBL] [Abstract][Full Text] [Related]
17. Berberine inhibits human neuroblastoma cell growth through induction of p53-dependent apoptosis.
Choi MS; Yuk DY; Oh JH; Jung HY; Han SB; Moon DC; Hong JT
Anticancer Res; 2008; 28(6A):3777-84. PubMed ID: 19189664
[TBL] [Abstract][Full Text] [Related]
18. [Celecoxib enhances chemosensitivity of oral cancer cells by blocking cell cycle progression in vitro].
Liao W; Yan Y; Huang Y; Li W
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jun; 33(6):885-8. PubMed ID: 23803204
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of the HGF/MET autocrine loop induced by celecoxib and mediated by P-gp in MDR-positive human hepatocellular carcinoma cell line.
Mazzanti R; Platini F; Bottini C; Fantappiè O; Solazzo M; Tessitore L
Biochem Pharmacol; 2009 Jul; 78(1):21-32. PubMed ID: 19447220
[TBL] [Abstract][Full Text] [Related]
20. [Effect of a selective COX-2 inhibitor on cell proliferation and apoptosis in human gastric cancer cell line BGC-823].
Li Q; Peng J; Zhang GY
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Dec; 33(12):1123-8. PubMed ID: 19141979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
